Company Cerenis Therapeutics Holding Euronext Paris
Equities
FR0012616852
Biotechnology & Medical Research
Business Summary
At the end of 2022, the company boasted a portfolio of 3 products in clinical development.
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Research
100.0
%
| 0 | 4.0 % | 5 | 100.0 % | +19,351.85% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 5 | 100.0 % | +678.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Director of Finance/CFO | - | 08-04-30 | |
Renee Benghozi
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-08 |
Chief Operating Officer | - | - | |
Laurent Guerci
PRN | Corporate Officer/Principal | - | 23-07-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Martinez
BRD | Director/Board Member | 54 | - |
Christian Chavy
BRD | Director/Board Member | 75 | 15-02-05 |
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Laura Coruzzi
BRD | Director/Board Member | 71 | 15-05-26 |
Karen Noël
BRD | Director/Board Member | 51 | 17-06-08 |
Emmanuel Huynh
CHM | Chairman | 54 | 19-08-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,439,382 | 22,076,290 ( 77.63 %) | 253,928 ( 0.8929 %) | 77.63 % |
Company contact information
ABIONYX Pharma SA
33-43, avenue Georges Pompidou Bâtiment D2
31130, Balma
+33 5 62 24 97 06
http://www.abionyx.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |